Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Celerion Transforms the Consent Experience for Sites and Patients with Veeva eConsent

Veeva Systems announced that Celerion adopted Veeva eConsent, a MyVeeva for Patients solution, to complete electronic consent for its Phase I clinical trials. With Veeva eConsent, Celerion is shifting from manual and paper-based informed consent to a completely digital process. The company is using Veeva eConsent across multiple studies and has consented more than 200 subjects.

Recommended AI News: Tata Communications and Cisco Systems Expand Global Strategic Partnership

“COVID-19 limited our time with participants, so we needed new and digital ways to keep our studies moving forward while remaining fully compliant with regulatory requirements regarding obtaining proper consent,” said Staci McDonald, executive director, scientific clinical operations at Celerion. “Veeva eConsent gives us an easy-to-use solution that can keep up with our fast-paced environment and improve participant comprehension of study procedures. Deploying the solution went smooth, with positive feedback from study teams, on-site staff, and participants.”

Related Posts
1 of 40,473

Recommended AI News: SYNLAB Expands Partnership with Feedtrail to Gain real-time Patient and Customer Feedback

A global leader in early clinical research services, Celerion uses Veeva SiteVault to digitally author, manage, and distribute informed consent forms (ICF). Patients can then access the eConsent document securely and complete the consenting process via a mobile device. This simplifies document reconciliation and reduces the administrative burden on sites. With a seamless flow of information, Celerion has complete visibility into consent status for improved study compliance and oversight.

“Celerion is advancing how the industry works together by using digital solutions that enable patient-centric, paperless clinical trials,” said Tim Davis, vice president, MyVeeva for Patients at Veeva Systems. “Veeva eConsent improves the informed consent process for all parties involved by delivering an intuitive and digital experience for patients and easy collaboration with sites and IRBs for sponsors.”

Recommended AI News: Springbrook Software Expands Product Offerings and Global Footprint with Acquisition of Public Sector Solution Provider MAGIQ Software

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.